AN2 Therapeutics
Business Services · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1800 El Camino Real Ste 100, Menlo Park,...Phone Number
(650) 331-9090Website
www.an2therapeutics.comRevenue
-Stock Symbol
ANTXIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
2
1
1
1
1
1
About AN2 Therapeutics
AN2 Therapeutics is a clinical-stage biopharmaceutical company developing boron-based drug candidates for infectious disease, hematology, and oncology. The company uses its chemistry platform to discover and advance novel therapies through preclinical research, clinical trials, and pipeline development aimed at serious unmet medical needs globallyExplore more
AN2 Therapeutics Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is AN2 Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on AN2 Therapeutics recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at AN2 Therapeutics
Click to see if AN2 Therapeutics had a recent Job posting/layoffs
Product Launch: Get notified when AN2 Therapeutics launches new products
Check out if AN2 Therapeutics is spiking on competitors!
Check if AN2 Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once AN2 Therapeutics has new funding data
AN2 Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Find VP level buyers at AN2 Therapeutics
Find 2 more new buyers
Compare Similar Companies to AN2 Therapeutics
Compare insights from companies similar to AN2 Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
AN2 Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
AN2 Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about AN2 Therapeutics.
AN2 Therapeutics financials insights
Gather financial insights about AN2 Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2019
Series A
$12M
2022
Series B
$80M
Stock Offering
$69M
2026
Stock/Share Issuance
$40M
AN2 Therapeutics Tech Stack
A closer look at the technologies used by AN2 Therapeutics
See more technologies
Most Recent Scoops
New Hire
Executive Move
Executive Moves, New Hire
Person-Based
Earnings, Pharmaceuticals, Clinical Operations, Finance
Project
AN2 Therapeutics has reported that oral epetraborole demonstrated efficacy comparable to IV imipenem the current gold standard in animal models of Mycobacterium abscessus, marking it as the first oral drug observed to match IV antibiotic performance in this disease model, and showed bactericidal activity superior to omadacycline's more bacteriostatic profile.
Project
AN2 Therapeutics has designed a three-part Phase II study in polycythemia vera, beginning with a 10-patient sentinel group at 250 mg every other day in Q3 of the current year to assess safety and pharmacokinetics, followed by an open-label dose titration phase and a randomized placebo-controlled component that includes patient-reported outcomes measuring fatigue and phlebotomy reduction.
Project
Medical Research, Pharmaceuticals
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding AN2 Therapeutics
Sign Up For FreeTo access detailed company insights
AN2 Therapeutics is a clinical-stage biopharmaceutical company developing boron-based drug candidates for infectious disease, hematology, and oncology. The company uses its chemistry platform to discover and advance novel therapies through preclinical research, clinical trials, and pipeline development aimed at serious unmet medical needs globally... Read More
